Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

RATIONALE & OBJECTIVE: In FIDELITY, finerenone improved cardiorenal outcomes in patients with chronic kidney disease (CKD) and type 2 diabetes. This analysis explores the efficacy and safety of finerenone in Hispanic patients. STUDY DESIGN: Post hoc analysis of the FIDELITY prespecified pooled a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosas, Sylvia E., Ruilope, Luis M., Anker, Stefan D., Pitt, Bertram, Rossing, Peter, Bonfanti, Andres Angelo Cadena, Correa-Rotter, Ricardo, González, Fernando, Munoz, Carlos Francisco Jaramillo, Pergola, Pablo, Umpierrez, Guillermo E., Scalise, Andrea, Scott, Charlie, Lawatscheck, Robert, Joseph, Amer, Bakris, George L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514441/
https://www.ncbi.nlm.nih.gov/pubmed/37745646
http://dx.doi.org/10.1016/j.xkme.2023.100704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514441/
https://www.ncbi.nlm.nih.gov/pubmed/37745646
http://dx.doi.org/10.1016/j.xkme.2023.100704

Ejemplares similares